SHAUN MACKEY: Open Payments
NPI 1891102372 · ALTAMONTE SPG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 16 payments from 10 companies in 2025. Trend: 2023 $250 · 2024 $250 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Grifols USA, LLC | 2 | $49 |
| Lilly USA, LLC | 1 | $29 |
| INOGEN, INC. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: GLASSIA, DUPIXENT, Prolastin-C Liquid, ZEPBOUND, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, TEZSPIRE, TEFLARO, JASCAYD.
Industry payments across FL — which companies pay providers there.
